A critical literature review of health economic evaluations of rotavirus vaccination
Rating :
Not applicable
Economic aspects
All age groups
Rotavirus
A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy
Rating :
Critically low
Efficacy/effectiveness
Newborn (0-1 years)
Children (2-9 years)
Rotavirus
Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines
Rating :
Not applicable
Economic aspects
All age groups
Rotavirus
Pneumococcal disease
Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus
Rating :
Critically low
Efficacy/effectiveness
Newborn (0-1 years)
Children (2-9 years)
Adolescents (10-18 years)
Cholera
Rotavirus
Background paper
Germany
Rotavirus
Download: